Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1

被引:179
作者
Yoo, YG
Kong, G
Lee, MO [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, BioMAX Inst, Seoul, South Korea
[3] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea
关键词
HDAC1; HIF-1; alpha; hypoxia; metastasis; MTA1;
D O I
10.1038/sj.emboj.7601025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of metastasis-associated protein 1 (MTA1) correlates well with tumor metastases; however, the associated molecular mechanism is not fully understood. Here, we explored the possibility of cross-talk between MTA1 and hypoxia-inducible factor-1 alpha (HIF-1 alpha), a key regulator of angiogenic factors. We observed that the expression of MTA1 was strongly induced under hypoxia in breast cancer cell lines such as MCF-7 and MDA-MB-231. When MTA1 was overexpressed, the transcriptional activity and stability of HIF-1 alpha protein were enhanced. MTA1 and HIF-1 alpha are physically associated in vivo and they were localized completely in the nucleus when coexpressed. MTA1 induced the deacetylation of HIF-1 alpha by increasing the expression of histone deacetylase 1 (HDAC1). MTA1 counteracted to the action of acetyltransferase, ARD1, and it did not stabilize the HIF-1 alpha mutant that lacks the acetylation site, K532R. These results indicate that acetylation is the major target of MTA1/HDAC1 function. Collectively, our data provide evidence of a positive cross-talk between HIF-1 alpha and MTA1, which is mediated by HDAC1 recruitment, and indicate a close connection between MTA1-associated metastasis and HIF-1-induced tumor angiogenesis.
引用
收藏
页码:1231 / 1241
页数:11
相关论文
共 51 条
  • [1] RETRACTED: Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis (Retracted article. See vol. 142, pg. 1388, 2015)
    Bagheri-Yarmand, R
    Talukder, AH
    Wang, RA
    Vadlamudi, RK
    Kumar, R
    [J]. DEVELOPMENT, 2004, 131 (14): : 3469 - 3479
  • [2] Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF
    Bilton, R
    Mazure, N
    Trottier, E
    Hattab, M
    Déry, MA
    Richard, DE
    Pouysségur, J
    Brahimi-Horn, MC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 31132 - 31140
  • [3] Mi-2/NuRD: multiple complexes for many purposes
    Bowen, NJ
    Fujita, N
    Kajita, M
    Wade, PA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2004, 1677 (1-3): : 52 - 57
  • [4] A conserved family of prolyl-4-hydroxylases that modify HIF
    Bruick, RK
    McKnight, SL
    [J]. SCIENCE, 2001, 294 (5545) : 1337 - 1340
  • [5] Dissemination and growth of cancer cells in metastatic sites
    Chambers, AF
    Groom, AC
    MacDonald, IC
    [J]. NATURE REVIEWS CANCER, 2002, 2 (08) : 563 - 572
  • [6] Cobalt chloride-induced estrogen receptor α down-regulation involves hypoxia-inducible factor-1α in MCF-7 human breast cancer cells
    Cho, JY
    Kim, D
    Lee, SK
    Lee, YJ
    [J]. MOLECULAR ENDOCRINOLOGY, 2005, 19 (05) : 1191 - 1199
  • [7] Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer:: Retrospective study in a series of 745 patients
    Dales, JP
    Garcia, S
    Meunier-Carpentier, S
    Andrac-Meyer, L
    Haddad, O
    Lavaut, MN
    Allasia, C
    Bonnier, P
    Charpin, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) : 734 - 739
  • [8] Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma
    de Ruijter, AJM
    Meinsma, RJ
    Bosma, P
    Kemp, S
    Caron, HN
    van Kuilenburg, ABP
    [J]. EXPERIMENTAL CELL RESEARCH, 2005, 309 (02) : 451 - 467
  • [9] Genetic basis of human breast cancer metastasis
    Debies, MT
    Welch, DR
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (04) : 441 - 451
  • [10] Clinical development of histone deacetylase inhibitors as anticancer agents
    Drummond, DC
    Noble, CO
    Kirpotin, DB
    Guo, ZX
    Scott, GK
    Benz, CC
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 495 - 528